Results 151 to 160 of about 940,352 (300)

Synchronous multiple primary neoplasms of the esophagus, rectosigmoid and central nervous system. [PDF]

Int J Surg Case Rep
Jena SS, Nundy S.
europepmc   +1 more source

Multiple malignant primary neoplasms

Journal of British Surgery, 1957
openaire   +2 more sources

Preoperative circulating tumor cells integrated with imaging analysis for prognostic evaluation in head and neck squamous cell carcinoma

Molecular Oncology, EarlyView.
Detecting circulating tumor cells (CTCs) in blood before surgery may help predict outcomes in patients with head and neck squamous cell carcinoma (HNSCC). Here, we show when combined with tumor size and lymph node involvement from routine imaging, CTC status identifies high‐risk patients with poorer survival—offering a simple, minimally invasive tool ...
Susanne Flach, Gizem Abaci, Tom Huberty, Axel Lechner, Lukas Käsmann, Jens Ricke, Sophia Stöcklein, Martin Canis, Philipp Baumeister, Marianna Alunni‐Fabbroni   +9 more
wiley   +1 more source

MiR‐513a promotes human erythroid differentiation by modulating c‐Jun

FEBS Open Bio, EarlyView.
During early human erythropoiesis, miR‐513a promoted erythroid differentiation in primary human CD34+ hematopoietic stem‐progenitor cells and human TF‐1 erythroleukemic cells by indirectly decreasing c‐Jun and phospho‐c‐Jun expression, which are associated with increased GATA1 expression.
MinJung Kim, Brittany Taylor, Shannon Bolten, Christian L. Eberly, Mahliya Abdurahman, T. Michael Creed, Acong Yang, Taylor L. Hatchet, Tristan Dyson, Shuo Gu, Curt I. Civin, Tami J. Kingsbury   +11 more
wiley   +1 more source

Combined 5‐aminolevulinic acid and ferric ammonium citrate treatment promotes hair follicle growth by activating dermal papilla cells

FEBS Open Bio, EarlyView.
5‐Aminolevulinic acid combined with ferric ammonium citrate (5‐ALA/FAC) stimulates dermal papilla cell activity and promotes hair follicle growth. The treatment enhances ERK and AKT signaling, increases hair‐inductive gene expression, and restores dermal papilla function suppressed by dihydrotestosterone and oxidative stress, resulting in enhanced hair
Han‐Wook Ryu, Eok‐Soo Oh, Sewoon Kim
wiley   +1 more source

Multiple primary malignant neoplasms in urologic patients

, 2003
Methods: Second primary cancers constitute approximately 9-10% of malignancies diagnosed in the United States. We aimed to show the risk and incidance of second primary tumor occuring associated to urologic tumors and show the distrubution of tumors in ...
Inci, Osman, Kaya, Esat, Atakan, Irfan Huseyin, Alagol, Bulent, Ereselli, Hasan, Aydin, Sabahattin   +5 more
core  

Real-world status of treatment for lymphoid neoplasms developed during the course of myeloproliferative neoplasms in Japan

Objectives: Patients with myeloproliferative neoplasms (MPNs) are at higher risk of developing secondary malignancies. In this study, we focused on patients with MPNs that complicated lymphoid neoplasms.
Takeshi Okatani, Makoto Sasaki, Atsuko Mugitani, Koh Izumiyama, Tomonori Ochiai, Naoki Takahashi, Yoko Edahiro, Tetsuya Nishida, Kensuke Usuki, Jun Ando, Yasutaka Fukuda, Tatsuo Oyake, Hiromi Omura, Tomoiku Takaku, Yoshinori Hashimoto, Michiko Ichii, Kenji Yokoyama, Miki Ando, Kei Nakajima, Junji Hiraga, Tomofumi Yano, Takafumi Nakao, Michiaki Koike, Eiichi Ohtsuka, Takashi Akasaka, Norio Komatsu   +25 more
core   +1 more source

Suppression of lung adenocarcinoma migration through organelle alkalization by human lactoferrin – albumin fusion

FEBS Open Bio, EarlyView.
This paper reveals how human lactoferrin–albumin fusion (hLF‐HSA) potently suppresses lung adenocarcinoma cell migration. hLF‐HSA upregulates NHE7, leading to Golgi alkalization, disruption of the Golgi secretome, downregulation of MMP1, and reversal of EMT. These findings suggest a novel Golgi‐targeting strategy to suppress cancer cell migration.
Hana Nopia, Masahiro Kimura, Daisuke Kurimoto, Atsushi Sato   +3 more
wiley   +1 more source

Multiple malignant primary tumors in dogs: an Italian registry-based epidemiological study. [PDF]

Front Vet Sci
Crescio MI, Cocumelli C, Carnio A, Carvelli A, Fonti N, Garcia-Vozmediano A, Galietta V, Eleni C, Ingravalle F, Manuali E, Maresca C, Millanta F, Razzuoli E, Scaramozzino P, Simeoni S, Vascellari M, Zanardello C, Ru G.   +17 more
europepmc   +1 more source

Pharmacological inhibition of the PERK pathway modulates hepatocellular carcinoma growth and immune signaling

FEBS Open Bio, EarlyView.
Pharmacological inhibition of PERK in a DEN‐induced mouse model of liver cancer does not reduce tumor burden but alters cellular stress signaling. Despite blocking PERK activity, downstream stress responses, including CHOP expression, remain active, suggesting compensatory mechanisms within the unfolded protein response that may influence tumor ...
Ada Lerma‐Clavero, Maria Kopsida, Nathalie Arendt, Hans Lennernäs, Markus Sjöblom, Femke Heindryckx   +5 more
wiley   +1 more source